Stereochemistry in inactivation of carboxypeptidase A. Structural analysis of the inactivated carboxypeptidase A by an enantiomeric pair of 2-benzyl-3,4-epoxybutanoic acids

Journal of the American Chemical Society

Volumn 119, Issue 1, 1997, Pages 38-41

  Ryu, Seong Eon ^a   Choi, Hee Jeong ^a   Kim, Dong H ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZYL 3,4 EPOXYBUTYRIC ACID; CARBOXYPEPTIDASE A; ENZYME INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ENANTIOMER; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; ENZYME MODIFICATION; ENZYME STRUCTURE; IN VITRO STUDY; X RAY ANALYSIS;

EID: 0031042263     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja9622463     Document Type: Article

References (41)

1. Christianson, D. W.; Lipscomb, W. N. Acc. Chem. Res. 1989, 22, 62-69, and references cited therein.
2. (b) Lipscomb, W. N. Proc. Natl. Acad. Sci. U.SA. 1980, 77, 3875-3878.
3. (a) Powers, J. C.; Harper, J. W. In Proteinase Inhibitors; Barrett, A. J., Salvesen, G., Eds.; Elsevier: Amsterdam, 1986; Chapter 6.
4. (b) Ondetti, M. A.; Rubin, B.; Cushman, D. W. Science 1977, 196, 441-444.
5. (c) Kim, D. H.; Guinosso, C. J.; Buzby, G. C., Jr.; Herbst, D. R.; McCaully, R. J.; Wicks, T. C.; Wendt, R. L. J. Med. Chem. 1983, 26, 394-403.
6. (d) Patchet, A. A.; Harris, E.; Tristram, E. W.; Wyvratt, M. J.; Wu, M. T.; Taub, D.; Peterson, E. R.; Ikeler, T. J.; Ten Broke, J.; Payne, N. G.; Ondeyka, D. L.; Thorsett, E. D.; Greenlee, W. J.; Lohr, N. S.; Hoffsommer, R. D.; Joshua, H.; Ruyle, W. V.; Rothrack, J. W.; Aster, S. D.; Maycock, A. L.; Robinson, F. M.; Hirschman, R. F.; Sweet, S. C.; Ulm, E. H.; Gross, D. M.; Vassil, T. C.; Stone, C. A. Nature (London) 1980, 288, 280-283.
7. (e) Dideberg, O.; Charlier, P.; Dive, G.; Joris, B.; Frere, J. M.; Ghuysen, J. M. Nature (London) 1982, 299, 469-470.
8. (f) Gafford, J. T.; Skidgel, R. A.; Erdös, E. G.; Hersh, L. B. Biochemistry 1983, 22, 3265-3271.
9. (g) Wahl, R. C.; Dunlap, R. P. Annual Reports Med. Chem. 1989, 25, 177-184.
10. (h) McKelvy, J. F.; Blumerg, S. Annul. Rev. Neurosci. 1986, 9, 415-434.
11. (i) Sutton, B. J.; Artymiuk, P. J.; Corders-Borboa, A. E.; Little, C.; Phillips, D. C.; Waley, S. G. Biochem. J. 1987, 248, 181-188.
12. (J) Payne, D. J. J. Med. Microbiol. 1993, 39, 93-99.
13. (k) Roques, B. P.; Noble, F.; Dauge, V.; Fournie-Zaluski, M.; Beaumont, A. Pharmacol. Rev. 1993, 45, 87-136.
14. (a) Ner, S. K.; Suckling, C. J.; Bell, A. R.; Wrigglesworth, R. J. Chem. Soc., Chem. Commun. 1987, 480-482.
15. (b) Kemp, A.; Tedford, M. C.; Suckling, C. J. Bioorg. Med. Chem. Lett. 1991, 1, 557-562.
16. (c) Kemp, A.; Ner, S. K.; Rees, L.; Suckling, C. J.; Tedford, M. C.; Bell, A. R.; Wriggleworth, R. J. Chem. Soc., Perkin Trans. 2 1993, 741-748.
17. (a) Mobashery, S.; Ghosh, S. S.; Tamura, S. Y.; Kaiser, E. T. Proc. Natl. Acad. Sci U.SA. 1990, 87, 578-582.
18. (b) Ghosh, S. S.; Wu, Y.-Q.; Mobashery, S. J. Biol. Chem. 1991, 266, 8759-8764.
19. (c) Tanaka, Y.; Grapsas, I.; Dakoji, S.; Cho, Y. J.; Mobashery, S. J. Am. Chem. Soc. 1994, 116, 7475-7480.
20. (a) Kim, D. H.; Kim, K. B. J. Am. Chem. Soc. 1991, 113, 3200-3202.
21. (b) Yun, M.; Park, C.; Kim, S.; Nam, D.; Kim, S. C.; Kim, D. H. J. Am. Chem. Soc. 1992, 114, 2281-2282.
22. (c) Kim, D. H.; Kim, Y. M.; Li, Z.-H.; Kim, K. B.; Choi, S. Y.; Yun, M.; Kim, S. Pure Appl. Chem. 1994, 66, 721-728.
23. (d) Lee, S. S.; Li, Z.-H.; Lee, D. H.; Kim, D. H. J. Chem. Soc., Perkin Trans. 1 1995, 2877-2882.
24. (e) Kim, D. H.; Chung, S. J. Bioorg. Med. Chem. Lett. 1995, 5, 1667-1672.
25. (a) Casy, A. F. The Steric Factors in Medicinal Chemistry; Dissymmetric Probes of Pharmacological Receptors; Plenum Press: New York, 1993.
26. (b) Crossley, R. Tetrahedron 1992, 48, 8155-8178.
27. (c) Drug Stereochemistry; Wainer, I. W., Drayer, D. E., Eds.; Marcel Dekker: New York, 1988.
28. (d) Sheldon, R. A. Chirotechnology; Marcel Dekker: New York, 1993.
29. (e) Benschop, H. P.; De Jong, L. P. A. Acc. Chem. Res. 1988, 21, 368-374.
30. (f) Montchamp, J.-L.; Piehler, L. T.; Frost, J. W. J. Am. Chem. Soc. 1992, 114, 4453-4459.
31. N1 which is thought to be the preferred process for the Lewis acid catalyzed ring cleavage: Lewars, E. G. In Comprehensive Heterocyclic Chemistry; Lwowski, W., Ed.; Pergamon Press: Oxford, 1984; Vol. 7, pp 108-109.
32. (a) Kim, D. H.; Kim, K. B. Bioorg. Med. Chem. Lett 1991, 1, 323-326 and references cited therein.
33. (b) Banci, L.; Schröder, S.; Kollman, P. A. Proteins 1992, 13, 288-305.
34. (a) Bartini, L.; Luchinat, C.; Messori, L.; Monnanni, R.; Auld, D. S.; Riordan, J. F. Biochemistry 1988, 27, 8318-8325.
35. (b) Bicknell, R.; Schaffer, A.; Bertini, L.; Luchinat, C.; Vallee, B. L., Auld, D. S. Biochemistry 1988, 27, 1050-1057.
36. (c) Christianson, D. W.; Mangani, S.; Shoham, G.; Lipscomb, W. N. J. Biol. Chem. 1989, 264, 12849-12853.
37. (d) Luchinat, C.; Monnanni, R.; Rolens, S.; Vallee, B. L.; Auld, D. S. J. Inorg. Biochem. 1988, 32, 1-6.
38. Nienaber, V. L.; Mersinger, L. J.; Kettner, C. A. Biochemistry 1996, 35, 9690-9699.
39. Mangani, S.; Carloni, P.; Orioli, P. J. Mol. Biol. 1992, 223, 573-578.
40. Hausrath, A. C.; Matthews, B. W. J. Biol. Chem. 1994, 269, 18839-18842.
41. Kim, D. H.; Jin, Y. Bioorg. Med. Chem. Lett. 1996, 6, 153-156.